Category: Washington Post

New book offers fresh details about chaos, conflicts inside Trump’s pandemic response

At one point, the president mused about repatriating infected Americans in Asia to Guantanamo Bay Naval Base.

Scientists battle over the ultimate origin story: Where did the coronavirus come from?

Speculation about origin abounds as the lab-leak theory puts a spotlight on virological research.

Calling mental health workers, not police, to deal with mental health crises

A 30-year-old Eugene, Ore., program has reduced calls to law enforcement, helped people and saved money. Other parts of the country are now starting similar programs.

Pandemic brought out something positive for some people — resilience

The toll of the past year led to greater hardships and mental health issues for many. But research indicates others emerged stronger and more successful. Here’s why.

CDC launches multistate investigation after imported rescue dog tests positive for rabies variant twice eradicated in U.S.

At least 12 people and 33 other dogs are confirmed to have been exposed to the rabid dog.

Cutting heart attacks, strokes possible even in young adults with poor cardiovascular health

Researchers used insurance data collected during routine health exams for 3.5 million young adults in South Korea between 2003 and 2004.

Addiction treatment had failed. Could brain surgery save him?

Brain surgery for substance use disorder will never be common. But for those who face imminent death, Gerod Buckhalter’s success — he has been sober for more than 600 days — points to what may be possible someday.

CDC investigating TB cases linked to tainted bone repair product used in more than 100 patients

The manufacturer of the bone repair product has recalled 154 containers of the material — a malleable bone putty that is used in a variety of orthopedic procedures.

The quest for a pill to fight viruses gets a $3.2 billion boost

The Biden administration will invest $3.2 billion to find new antiviral drugs, modeling the investment after the one that helped stimulate development of drugs that transformed HIV.

Furor rages over FDA approval of controversial Alzheimer’s drug

For days, critics have blasted the approval in opinion columns and tweets, saying there is insufficient evidence of efficacy. Supporters have expressed confidence the drug, Aduhelm, will help patients stay in the earliest stages of the disease longer.